MBX Biosciences, Inc. MBX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.21M+51.2% | $75.29M+52.6% | $223.13M+67.9% | $39.78M— | $29.9M— | ||
| $394.76M+87.2% | $298.42M+40.2% | $168.55M+16.9% | $185.13M— | $210.88M— | ||
| $8.56M+145% | $7.83M+52.5% | $5.83M+41.9% | $4.28M+270% | $3.49M+955% | ||
| $448.54M+83.6% | $381.54M+42.7% | $397.5M+41.4% | $229.19M— | $244.28M— | ||
| $3.13M+108% | $2.74M+153% | $2M+94.0% | $1.73M— | $1.51M— | ||
| $453K+398% | $487K+309% | $520K+254% | $551K— | $91K— | ||
| $579K+1,058% | $383K+666% | $50K0.0% | $50K— | $50K— | ||
| $452.7M+84.1% | $385.14M+43.4% | $400.08M+41.7% | $231.52M— | $245.93M— | ||
| $6.97M+64.3% | $2.98M-44.2% | $3.77M-24.7% | $5.76M+896% | $4.25M+796% | ||
| $7.42M+21.4% | $12.35M+123% | $8.14M+41.5% | $5.85M— | $6.11M— | ||
| $178K+36.9% | $172K+0.6% | $154K-7.2% | $138K— | $130K— | ||
| $14.57M+39.0% | $15.5M+40.2% | $12.06M+10.5% | $11.76M— | $10.48M— | ||
| $377K— | $424K— | $469K+966% | $512K— | —— | ||
| $14.95M+42.3% | $15.92M+43.5% | $12.54M+13.7% | $12.28M— | $10.5M— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $6K+20.0% | $6K+20.0% | $6K+20.0% | $5K— | $5K— | ||
| $686.35M+73.0% | $593.41M+50.3% | $589.79M+50.0% | $400.02M— | $396.75M— | ||
| -$247.99M-53.7% | -$224.48M-63.2% | -$202.41M-66.0% | -$180.8M— | -$161.39M— | ||
| -$606K-1,243% | $286K+420% | $154K+45.3% | $11K— | $53K— | ||
| —— | —— | —— | —— | —— | ||
| $437.76M+85.9% | $369.22M+43.4% | $387.54M+42.8% | $219.24M+324% | $235.42M+383% | ||
| $452.7M+84.1% | $385.14M+43.4% | $400.08M+41.7% | $231.52M— | $245.93M— | ||
| $394.76M+87.2% | $298.42M+40.2% | $168.55M+16.9% | $185.13M— | $210.88M— | ||
| $579K+1,058% | $383K+666% | $50K0.0% | $50K— | $50K— | ||
| $453K+398% | $487K+309% | $520K+254% | $551K— | $91K— | ||
| $453K+398% | $487K+309% | $520K+254% | $551K— | $91K— | ||
| $579K+1,058% | $383K+666% | $50K0.0% | $50K— | $50K— | ||
| $453K+398% | $487K+309% | $520K+254% | $551K— | $91K— | ||
| $579K+1,058% | $383K+666% | $50K0.0% | $50K— | $50K— | ||
| $7.42M+21.4% | $12.35M+123% | $8.14M+41.5% | $5.85M— | $6.11M— | ||
| $7.42M+21.4% | $12.35M+123% | $8.14M+41.5% | $5.85M— | $6.11M— | ||
| $555K+327% | $596K+249% | $623K+197% | $650K— | $130K— | ||
| $686.35M+73.0% | $593.41M+50.3% | $589.79M+50.0% | $400.02M— | $396.75M— | ||
| $6K+20.0% | $6K+20.0% | $6K+20.0% | $5K— | $5K— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1K-95.7% | $2K-95.2% | $7K-89.7% | $15K— | $23K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MBX Biosciences, Inc.'s total assets?
- MBX Biosciences, Inc. (MBX) holds $452.7M in total assets, up 84.1% year over year.
- How much debt does MBX Biosciences, Inc. have?
- MBX Biosciences, Inc. carries $555.0K in total debt against $437.8M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does MBX Biosciences, Inc. have?
- MBX Biosciences, Inc. holds $45.2M in cash and equivalents.
- Can MBX Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 30.79 — current assets exceed current liabilities.
- Where does MBX Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.